• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Age, cardiac comorbidities linked to increased risk of trastuzumab-related CHF

bys25qthea
October 19, 2013
in Cardiology, Chronic Disease, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Patients of increasing age or comorbid cardiac conditions were found to be at an increased risk of trastuzumab-related congestive heart failure (CHF). 

2. Further studies are needed to confirm an association between frequency of administration and CHF. 

Evidence rating level: 2 (Good) 

Study Rundown: Trastuzumab, a humanized monoclonal antibody, is used in the treatment of breast cancer patients. Though it is associated with improved outcomes when used in adjuvant chemotherapy, it is also linked with cardiotoxicity at rates from 2% to as high as 27% when used in combination with anthracyclines. It remains unclear what risk factors are associated with this toxicity, and the purpose of this study is to help identify these factors.

After analyzing a large cohort of breast cancer patients, the study authors observed  that those receiving trastuzumab were at higher risk for CHF. They also found that among these patients, older age, coronary artery disease and hypertension were associated with CHF. Finally, weekly trastuzumab administration increased the risk of this complication. These results help confirm that older age and cardiac comorbidities are associated with trastuzumab cardiotoxicity, though further studies will be needed to determine the relationship between frequency of administration and CHF.  It should be noted that this was a retrospective study and in addition the authors were unable to evaluate the impact CHF had on quality of life or performance status of these patients, or data on antihypertensive medications, smoking or obesity.

RELATED REPORTS

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

Click to read the study in JCO

Relevant reading: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

In-Depth [retrospective cohort study]: The study authors collected patients from the SEER-Medicare and the Texas Cancer Registry-Medicare databases who were at least 66 years old, diagnosed with breast cancer between 2005 and 2009, and treated with chemotherapy. A total of 9535 patients were included, of whom 2203 (23.1%) received trastuzumab. Rates of CHF and chemotherapy, trastuzumab use, coronary artery disease and hypertension were then retrospectively determined.

It was observed that trastuzumab users had an increased rate of CHF compared to non-trastuzumab users (29.4% vs 18.9% ;P < 0.001). The authors also found that among treated patients, older age (age > 80 years; HR, 1.53 CI 1.16-2.1), coronary artery disease (HR, 1.82; 95% CI, 1.34-2.48), hypertension (HR, 1.24; 95% CI, 1.02-1.5) and weekly trastuzumab administration (HR, 1.33; 95% CI 1.05-1.68) all were linked with an increased the risk of CHF.

By Monica Parks and Andrew Bishara

More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: Breast Cancercongestive heart failure
Previous Post

Motion Displacement Test is accurate in screening for glaucoma

Next Post

Aspirin vs warfarin in atherosclerotic intracranial stenosis [Classics Series]

RelatedReports

Atrial fibrillation-specific management increases days alive and out of hospital
Cardiology

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

July 4, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

July 2, 2025
Chronic Disease

Breast cancer survivors may have a lower risk of Alzheimer’s dementia

July 2, 2025
3D mammography (tomosynthesis) enhances accuracy of breast cancer screening
Chronic Disease

Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts

June 25, 2025
Next Post

Aspirin vs warfarin in atherosclerotic intracranial stenosis [Classics Series]

Children born late preterm birth at higher odds to fail standardized tests

Non-invasive respiratory support superior to invasive measures in preterm infants

Patient centeredness poor predictor of fertility care dropout

Donor oocyte IVF making strides

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Seventh cervical nerve neurotomy may augment speech therapy in patients with chronic aphasia post-stroke
  • Time-restricted eating does not confer changes in sleep, mood, or quality of life
  • Commonly cited medication triggers may not increase risk of microscopic colitis among older adults
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.